Magellan Health (MGLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | |
| Sales | 1,465,918 |
| Gross Profit | 463,140 |
| Operating Expenses | 1,350,710 |
| Operating Income | 115,208 |
| Interest Expense | 93,752 |
| Other Income | 16,001 |
| Pre-tax Income | 37,457 |
| Income Tax | 21,674 |
| Net Income Continuous | 15,383 |
| Net Income Discontinuous | -10,465 |
| Net Income | $4,688 |
| EPS Diluted Total Ops | 0.15 |
| EPS Diluted Continuous Ops | 0.49 |
| EPS Diluted Discontinuous Ops | -0.33 |
| EBITDA(a) | $133,598 |